Buyback yield (TTM)
0.14%
Shareholder yield (TTM)
0.14%
5Y share count change
-8.0%
Buyback spend (TTM)
$25.98M
Cumulative buybacks
$2.03B
Key takeaways
- Incyte (INCY) repurchased about $25.98M of stock over the trailing twelve months.
- Diluted share count is down 8.0% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 0.10× — repurchases only partially offset SBC dilution.
- TTM repurchases used about 2% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Incyte (INCY)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Incyte (INCY)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Incyte (INCY)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Incyte (INCY)
Latest: $19.10M
Overview
Incyte (INCY) most recent annual buyback spend stands at $19.10M (2025) – plunged 99.0% year-over-year.
Between 2024 and 2025, Incyte buyback spend plunged 99.0%, falling from $2.00B to $19.10M.
The highest annual buyback spend of $2.00B was reported in 2024. The lowest in the available history was $0.00 in 1993.
Incyte Buyback Spend 2025: $19.10M
2025's buyback spend for Incyte came in at $19.10M, plunged 99.0% below 2024.
Incyte Buyback Spend 2024: $2.00B
Incyte buyback spend in 2024 was $2.00B.
Incyte Buyback Spend 2023: $0.00
Incyte buyback spend in 2023 was $0.00.
Incyte Buyback Spend 2022: $0.00
Incyte buyback spend in 2022 was $0.00.
Incyte Buyback Spend 2021: $0.00
Incyte buyback spend in 2021 was $0.00.
See more financial history for Incyte (INCY).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $19.10M | $249.35M | −$230.25M | 0.10% | 0.20B | -4.7% | |
| 2024 | $2.00B | $266.06M | $1.74B | 15.03% | 0.21B | -6.8% | |
| 2023 | $0.00 | $215.89M | −$215.89M | — | 0.23B | +0.9% | |
| 2022 | $0.00 | $188.42M | −$188.42M | — | 0.22B | +0.8% | |
| 2021 | $0.00 | $183.01M | −$183.01M | — | 0.22B | +1.8% | |
| 2020 | $0.00 | $177.88M | −$177.88M | — | 0.22B | +0.2% | |
| 2019 | $0.00 | $166.59M | −$166.59M | — | 0.22B | +0.9% | |
| 2018 | $0.00 | $148.15M | −$148.15M | — | 0.22B | +5.4% | |
| 2017 | $0.00 | $133.06M | −$133.06M | — | 0.20B | +5.4% | |
| 2016 | $0.00 | $96.20M | −$96.20M | — | 0.19B | +3.6% | |
| 2015 | $0.00 | $69.87M | −$69.87M | — | 0.19B | +11.5% | |
| 2014 | $0.00 | $62.16M | −$62.16M | — | 0.17B | +13.2% | |
| 2013 | $0.00 | $38.40M | −$38.40M | — | 0.15B | +14.4% | |
| 2012 | $0.00 | $38.49M | −$38.49M | — | 0.13B | +3.5% | |
| 2011 | $0.00 | $28.98M | −$28.98M | — | 0.13B | +3.1% | |
| 2010 | $0.00 | $14.86M | −$14.86M | — | 0.12B | +18.2% | |
| 2009 | $0.00 | $9.98M | −$9.98M | — | 0.10B | +14.7% | |
| 2008 | $0.00 | $15.03M | −$15.03M | — | 0.09B | +6.7% | |
| 2007 | $0.00 | $8.89M | −$8.89M | — | 0.08B | +0.5% | |
| 2006 | $0.00 | $8.89M | −$8.89M | — | 0.08B | +0.6% | |
| 2005 | $0.00 | $186.00K | −$186.00K | — | 0.08B | +11.8% | |
| 2004 | $0.00 | $463.00K | −$463.00K | — | 0.07B | +4.5% | |
| 2003 | $105.00K | $4.10M | −$3.99M | 0.02% | 0.07B | +5.9% | |
| 2002 | $5.72M | $4.10M | $1.63M | 1.86% | 0.07B | +1.8% | |
| 2001 | $0.00 | $0.00 | $0.00 | — | 0.07B | +4.7% | |
| 2000 | $0.00 | $0.00 | $0.00 | — | 0.06B | +12.3% | |
| 1999 | $0.00 | $0.00 | $0.00 | — | 0.06B | -2.6% | |
| 1998 | $0.00 | $0.00 | $0.00 | — | 0.06B | +8.9% | |
| 1997 | $0.00 | $0.00 | $0.00 | — | 0.05B | +32.7% | |
| 1996 | $0.00 | $0.00 | $0.00 | — | 0.04B | — | |
| 1995 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1993 | $0.00 | $0.00 | $0.00 | — | — | — |
- 2025$19.10M
- 2024$2.00B
- 2023$0.00
- 2022$0.00
- 2021$0.00
- 2020$0.00
- 2019$0.00
- 2018$0.00
- 2017$0.00
- 2016$0.00
- 2015$0.00
- 2014$0.00
- 2013$0.00
- 2012$0.00
- 2011$0.00
- 2010$0.00
- 2009$0.00
- 2008$0.00
- 2007$0.00
- 2006$0.00
- 2005$0.00
- 2004$0.00
- 2003$105.00K
- 2002$5.72M
- 2001$0.00
- 2000$0.00
- 1999$0.00
- 1998$0.00
- 1997$0.00
- 1996$0.00
- 1995$0.00
- 1994$0.00
- 1993$0.00
Buybacks vs stock-based compensation for Incyte (INCY)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.10×.
Buybacks vs dividends (share of cash returned) for Incyte (INCY)
How Incyte splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Incyte, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $1.45B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation